These data provided evidence that high expression and activity of Chk-α along with high level of PC levels can play a role in mediating TAM resistance and Chk-α downregulation may provide an alternative to abrogate the TAM resistance and enhance the therapeutic response to anti-esteogen, TAM in ER+ cancer cells and tumors. The gene discussed is CHKA; the disease is cancer.